Dicyclomine Use in Irritable Bowel Syndrome

Primary Indication and Patient Selection

Patients with predominant abdominal pain and cramping as their primary IBS symptom are best candidates for dicyclomine, according to the British Society of Gastroenterology guidelines 1, 2
The British Society of Gastroenterology guidelines identify anticholinergic agents like dicyclomine as showing the most significant improvement in pain among antispasmodics, though dry mouth is a common limiting side effect 2

Dicyclomine is positioned as a first-line pharmacologic treatment for IBS-related abdominal pain, alongside other antispasmodics, and should be used after initial dietary modifications have been attempted 1, 3
The American Gastroenterological Association recommends starting with lower doses and titrating based on tolerance, as anticholinergic side effects are common 1

Dicyclomine should not be used as a first choice for constipation-predominant IBS, as anticholinergic effects may worsen constipation 2
The British Society of Gastroenterology guidelines suggest that tricyclic antidepressants are more effective for chronic visceral pain syndromes and patients with significant psychological comorbidities 2
Peppermint oil is equally effective for global symptoms and abdominal pain with fewer anticholinergic effects, though gastroesophageal reflux may occur 4

The American Gastroenterological Association suggests antispasmodics as a class for IBS with conditional recommendation and low certainty evidence, noting only dicyclomine, hyoscine, and peppermint oil are available in the United States 5

Dicyclomine worsens constipation through anticholinergic effects, limiting use in constipation-predominant IBS, with a notable difference in side effect profile compared to drotaverine 5